Gabriel Chabo

Associate
  • Stockholm
  • Languages:
    Swedish, English

Education

  • Stockholm University, LL.M., 2021

Experience

  • Summer Trainee, Vinge, 2020
  • Legal trainee (Talangpool), Vinge, 2019-2020

Mandates

Mandate January 22, 2024

Vinge advises La Française des Jeux SA on its public offer for Kindred Group plc

La Française des Jeux SA, France’s national lottery and leading betting and gaming operator, has ann…

Mandate October 13, 2023

Vinge advises Studentbostäder i Norden AB (publ) in connection with its rights issue and written procedure in relation to its notes

Vinge is advising Studentbostäder i Norden AB (publ), a real estate company whose shares are listed…

Mandate March 29, 2023

Vinge has advised CTEK in connection with its rights issue  

Vinge has advised CTEK AB (publ) on a fully guaranteed rights issue, which will provide CTEK with is…

Mandate February 15, 2023

Vinge advises Biotage in connection with its acquisition of Astrea from KKR’s life science platform Gamma

Vinge advises Biotage AB (publ) (“Biotage”) in connection with its acquisition of Astrea Bioseparati…

Mandate February 10, 2023

Vinge has advised Neobo Fastigheter in connection with the listing of Neobo Fastigheter’s shares on Nasdaq First North Premier

Vinge has advised Neobo Fastigheter AB (publ) (”Neobo”) in connection with the listing of Neobo’s sh…

Mandate January 24, 2023

Vinge has advised SBB in connection with the distribution of the shares in Neobo Fastigheter

Vinge has advised Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) in connection with the distribu…

Mandate October 18, 2022

Vinge has advised Xspray Pharma in connection with share issue

Vinge has advised Xspray Pharma, a pharmaceutical company with several product candidates in clinica…

Mandate May 20, 2022

Vinge has advised Re:NewCell in connection with a directed share issue

Vinge has advised Re:NewCell, a textile-to-textile recycling company listed on Nasdaq First North Pr…

Mandate May 05, 2022

Vinge advises A3P Biomedical in conjunction with directed share issue

Vinge has advised A3P Biomedical in connection with an issue of shares amounting to SEK 400 million…